Moderna (NASDAQ: $MRNA) stock experienced a surge of approximately 14% on Thursday following news that its personalized cancer vaccine, developed in collaboration with Merck (MRK), […]
Category: Biotech
Vertex Pharmaceuticals (NASDAQ: $VRTX) Jumps on Phase 2 Results For Opioid Alternative
Vertex Pharmaceuticals (NASDAQ: $VRTX) released encouraging results from its Phase 2 trial of a pain medication designed to address diabetic peripheral neuropathy (DPN) on Wednesday. […]
Aditxt, Inc. (NASDAQ: $ADTX) Enters into Definitive Agreement to Acquire Evofem Biosciences
Aditxt, Inc. (NASDAQ: ADTX) is a life science company working on technologies to improve the immune system health. The company is developing immune reprogramming and […]
C4 Therapeutics, Inc. (NASDAQ: $CCCC) Announces License & Research Collaboration with Merck
C4 Therapeutics, Inc. (NASDAQ: CCCC) is a clinical-stage biotech company. It is working to create a new generation of medicines using targeted protein degradation science […]
ImmunoGen, Inc. (NASDAQ: $IMGN)
ImmunoGen, Inc. (NASDAQ: $IMGN) is a biotechnology company operating in the commercial stage. The company is dedicated to the development and commercialization of antibody-drug conjugates […]
RedHill Biopharma Ltd. (NASDAQ: $RDHL)
RedHill Biopharma Ltd, (NASDAQ: $RDHL) headquartered in Israel, is a specialized biopharmaceutical company primarily concentrating on gastrointestinal and infectious diseases. RedHill markets gastrointestinal drugs like […]